Categories: HealthcareNews

Candid Health Announces $29 Million Series B Led by 8VC to Transform Revenue Cycle Automation

SAN FRANCISCO, CA / ACCESSWIRE / September 11, 2024 / Candid Health, the revenue cycle automation platform for healthcare providers, today announced a $29 million Series B led by 8VC with participation from existing investors First Round Capital, BoxGroup, and Y Combinator. This brings the company’s total amount raised to $47 million.

Candid Health is on a mission to simplify medical billing, allowing providers to focus on delivering quality care. The complex and outdated U.S. healthcare system costs $280 billion annually, with more than 1,000 payors and ever-evolving requirements leading to slow, error-prone manual processes – a prime candidate for automation.

Where traditional technology has struggled to keep up with the complexities of changing regulations and the claims cycle, Candid Health’s modern platform uses automation to transform billing.

“Candid Health transformed the way we do business. We went from a manual process with virtually every claim needing hands-on work to automation that submits claims efficiently and correctly. As a fast-growing healthcare provider, technology like this is crucial to our success,” said Stephanie Liu, Co-founder, Nourish. “Candid Health has helped us achieve best-in-class collection rates while enabling us to deliver better service to our patients.”

By streamlining the entire process — from claim submissions to accounts receivable-manual interventions are eliminated, and claims are auto-corrected. The impact to its more than 150 customers is clear: Candid’s highest-performing customers are consistently able to achieve 95-99% first pass resolution and net collection rates, ensuring accurate payment the first time.

“Most medical billing companies focus on resolving issues post-claims submission more efficiently, but we’re flipping the model. We focus on submitting claims correctly the first time so that there are no issues to fix,” said Nick Perry, CEO and co-founder of Candid Health. “We’ve been rethinking medical billing from the ground up to automate complexity. This ensures healthcare providers can get paid, on time, and for less cost.”

“Candid Health brings urgently needed simplicity to the complexity that characterizes medical billing,” said Sebastian Caliri, Partner, 8VC. “They’ve substantially automated claim preparation and submission — reducing human error and manual interventions — building on data architecture that enables continuous improvement and expansion into new workflows. It’s a privilege to renew our support for one of the best teams and most important missions in healthcare.”

####

About Candid Health

Candid Health is on a mission to simplify medical billing, allowing providers to focus on delivering quality care. Trusted by more than 100 leading organizations, our revenue cycle platform uses automation to transform billing. The company is backed by 8VC, Y Combinator, First Round Capital, and Boxgroup. Learn more at https://www.joincandidhealth.com/company.

Contact Information

Adrienne Chen
Noted Marketing for Candid Health
adrienne@noted-marketing.com

SOURCE: Candid Health

View the original press release on newswire.com.

Staff

Recent Posts

Hemogenyx Pharmaceuticals PLC – Issue of Equity

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE…

3 hours ago

1933 Industries Announces Maturity of Unsecured Convertible Debentures and Encourages Conversion to Support Continued Growth

VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / 1933 Industries Inc. (the "Company"…

3 hours ago

Bupa Hong Kong has selected Cognizant to deliver an AI-driven BPaaS solution to transform health insurance claims

Strategic collaboration aims to enhance operational efficiency and mitigate risks by transitioning to a business…

6 hours ago

DiagnosTear Signs Non-Binding Term Sheet with Sheba Impact and Ramot to Exclusively License New Eye Imaging Technology, CLARIFY, Enabling Needle-Free Blood Count

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

12 hours ago

CranioSense Awarded $5.5 Million in Federal Grants to Validate Noninvasive Neurotech

BOSTON, Dec. 17, 2025 /PRNewswire/ -- CranioSense, Inc., a neurotechnology company developing the world's first noninvasive…

12 hours ago

Therap Services Announces 2026 National Conference Schedule: Highlighting New Tools, Best Practices, and Over 250 Specialized Sessions

TORRINGTON, Conn., Dec. 17, 2025 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic…

12 hours ago